 |
||||||||||||||||||||
|
Partners
Keystone Symposia on Molecular and Cellular Biology is a nonprofit organization that organizes and administers open, international scientific meetings in the biomedical and life sciences. Based on a rigorous peer review process, the conferences are renowned for the excellence of the science presented and for the stimulating venues where key research collaborations form, younger scientists receive mentoring and support, and innovative scientific thinking evolves.
PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare and investment community; Performs due diligence research and provides expert commentary in healthcare. Reports combine scientific analysis with market modeling to forecast a drugs potential revenue stream, key drivers and market trends.
mAbs is a new peer-reviewd journal launched in 2009 and published by Landes Bioscience. It is the first international peer-reviewed journal to provide a forum for communication on the topic of monoclonal antibody research and development, with a focus on therapeutics.
Cancer Biology & Therapy is a new peer-reviewed journal that publishes original research on the molecular basis of cancer, including articles with translation relevance to diagnosis or therapy. The goal is to foster communication and the rapid exchange of information through expedient publication of important results, using tranditional as well as electronic formats. Cancer Biology & Therapy will become essential to the cancer community, publishing outstanding original research, along with reviews, analyses, and opinion pieces on the ever increasing spectrum of cancer research. The world class editorial board will strive to maintain the highest standards of excellence in generating this valuable resource.
The Scientist, the award-winning magazine of the life sciences, provides compelling print and online coverage of the latest developments in the life sciences including research, technology, and business. We entertain and inform our readers, keeping them up-to-date with research advances, events, culture, technical innovations and career advice.
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market.
Drug Discovery Today is a review journal, published as 12 monthly double issues. The journal covers the whole of the preclinical drug discovery process, from target identification and validation, through hit identification, lead identification and optimisation, though to candidate selection. The reviews are at the cutting edge of the science underpinning drug discovery, written by experts in their respective fields and cover all aspects of drug discovery from state-of-the-art genomic and proteomic approaches to target identification, through the most innovative computational approaches to drug design, the science driving medicinal chemistry and the translation of these sciences to therapies. Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting in- and out-licensing activities, Pharmalicensing provides partnering services, business development reports, industry news and a jobs source for candidates and employers.
Every weekly issue of Cancer Drug News reports the important news on the companies, products, alliances and research that are shaping global cancer markets with regular sections on cancers affecting the brain, breast, GI tract, genito-urinary system, gynaecological system, blood and lung as well as melanoma/sarcoma.
Anyone who needs to understand the operating landscape for diagnostics need look no further than Diagnostics Focus.
Biomarkers in Medicine is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice. For more information please see http://www.futuremedicine.com/loi/bmm
Future Oncology takes a forward-looking stance toward scientific and clinical issues, together with the economic and policy issues, that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. For more information please see http://www.futuremedicine.com/loi/fon
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. For more information please see http://www.futuremedicine.com/loi/pgs
Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. For more information please see http://www.futuremedicine.com/loi/pme
Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. All articles are subject to rigorous peer-review. For more information please visit http://www.expert-reviews.com/loi/era
TouchOncology.com is an independent specialist website that supports physicians, clinicians, and related healthcare professionals in continuously developing their knowledge, effectiveness, and productivity. It features balanced and comprehensive peer-reviewed articles written by leading authorities as well as case reports, guidelines, theoretical discussions, and original research.
Cancer Investigation delivers the latest translational cancer research discoveries that bridge the gap between the laboratory and the clinic. Under the expert leadership of Dr. Gary Lyman and his distinguished editorial board, Cancer Investigation is now focused to better represent the revolution in our understanding of cancer and its management.
With a focus on Greater China's growing life science sector, BiotechEast offers international biotech companies, institutes and investors the resources and services they need to find opportunities in the region. Whether drug discovery, medtech, pharma or nutraceuticals, our in-house industry experts are dedicated to provided results for our customers. BiotechEast also operates the most comprehensive English-language biotech website in greater China — www.biotecheast.com.
BioMed Central (www.biomedcentral.com) is an STM (Science, Technology and Medicine) publisher and a pioneer of the open access publishing model. BioMed Central publishes over 190 peer-reviewed open access journals, including Molecular Cancer (http://www.molecular-cancer.com/) and Breast Cancer Research (http://breast-cancer-research.com/). BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
©Copyright Phacilitate Limited 2009
|
 Program development has now started – complete a Shape your Event form to contribute your views.
|
||||||||||||||||||
